首页> 美国卫生研究院文献>Clinical Medicine Insights. Oncology >Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation

【2h】

Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation

机译：作为肝细胞癌复发和劣质生存后的免疫肿瘤危险因素的交叉匹配：呼吁进一步调查

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The success of immunotherapy for patients with hepatocellular carcinoma (HCC) suggests that immune dysregulation occurs in HCC patients. This warrants an immuno-oncological risk assessment in the platform of liver transplantation.

机译：免疫疗法对肝细胞癌患者的成功表明，在HCC患者中发生免疫失调。这令肝脏移植平台中的免疫肿瘤风险评估。

著录项

期刊名称 Clinical Medicine Insights. Oncology
作者
Cheng-Maw Ho; Rey-Heng Hu; Yao-Ming Wu; Ming-Chih Ho; Po-Huang Lee;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

机译：肝细胞癌;肝移植;复发;危险因素;免疫肿瘤学;交叉匹配;

相似文献

外文文献
中文文献
专利

1. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: Comparable survival and recurrence [J] . Sandhu L., Sandroussi C., Guba M., Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society . 2012,第3期

机译：活体供体肝移植与已故供体肝移植治疗肝细胞癌：可比的生存和复发
2. Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma [J] . Abdel-WahabM., SultanA.M., FathyO.M., Hepato-gastroenterology. . 2013,第128期

机译：活体供肝肝移植术后肝癌复发和生存的影响因素
3. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: With special reference to neutrophil/lymphocyte ratio [J] . HarimotoN., ShirabeK., NakagawaraH., Transplantation: Official Journal of the Transplantation Society . 2013,第11期

机译：供体肝移植后影响肝细胞癌复发生存的预后因素：特别涉及中性粒细胞/淋巴细胞比
4. Surgical treatment for hepatocellular carcinoma: the role of living donor liver transplantation [C] . C. VALENTIN GAMAZ, C. E. BROELSCH, M. MALAGO Falk Workshop . 2003

机译：肝细胞癌的外科治疗：生活供体肝移植的作用
5. Splenectomy in living donor liver transplantation and risk factors of portal vein thrombosis [D] . Kurata Nobuhiko, 倉田信彦 2019

机译：活体供体肝脾切除术及门静脉血栓形成的危险因素
6. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma [O] . Gun H. Na, Eun Y. Kim, Tae H. Hong, 2016

机译：活体供体肝移植前局部治疗对韩国肝细胞癌患者总生存和无复发生存的影响
7. Cross-match as an immuno-oncological risk factor for hepatocellular carcinoma recurrence and inferior survival after living donor liver transplantation: A call for further investigation [O] . Cheng-Maw HO, Rey-Heng HU, Yao-Ming WU, 2021

机译：作为肝细胞癌复发和劣质生存后的免疫肿瘤危险因素的交叉匹配：呼吁进一步调查

Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation

摘要

著录项

相似文献

相关主题

期刊订阅